Drugs body CDSCO suspends import licences of 19 firms for non-USFDA COVID-19 testing kits
The decision was taken after the drug controller found the companies' response to a 17 July show-cause notice asking them to explain why their licences should not be suspended unsatisfactory
New Delhi: The Central Drugs Standard Control Organisation (CDSCO) has suspended the import licenses of at least 19 firms for their respective COVID-19 test kits after USFDA removed the manufacturer from their list of the product of serology test kits for coronavirus .
"The top drug regulator has suspended the import license for about 16 companies and cancelled the license for three firms on similar grounds," a senior health ministry official said to ANI while confirming the development.
"The import license has been suspended for companies like Aracion technology private limited, Diasys diagnostic India Private limited, Saffron Naturele Products Private Limited, Cosmic Scientific Technologies, SD Biosensors Healthcare Private Limited, Transasia Bio-Medicals has been cancelled whereas it has been cancelled for MDAAC International Private Limited, Cadila healthcare limited and NW Overseas Private Limited," informed the official requesting anonymity.
On 17 July, all the companies were issued a show-cause notice from the top drug controller asking why its import license shall not be cancelled since the rapid diagnostic kit of the manufacturer has been removed by US Food and Drug Administration (USFDA) with direction that it should not be distributed from the list of the product of serology test kits for coronavirus disease.
"And whereas your response to the show-cause notice has not been found satisfactory with respect to removal of said kit, by USFDA from their list mentioning not to distribute. However, it has been mentioned by you to not to cancel your said import for the above product," stated the notice, a copy of which is with ANI.
"Therefore in public interest your import license for the above product becomes inoperative and stands suspended, till further orders," the notice read.
Further, the Drug Controller General of India (DCGI) directed that no batches of the said diagnostic kit shall be imported for sale/stock/distribution or sold or offered for sale, the notice stated.
Japan has extended the ongoing state of emergency in Tokyo and 18 other areas until 30 September
Health officials in China said this week that more than one billion people, or 72 percent of the country's 1.4 billion citizens, have been fully vaccinated.
A joint statement from motorcycling's governing body the FIM and promotors Dorna confirmed the grand prix at the Termas de Rio Honda circuit, for which no date had been fixed, was off due to "force majeure".